BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9174367)

  • 1. Isolation of hammerhead ribozymes with altered core sequences by in vitro selection.
    Vaish NK; Heaton PA; Eckstein F
    Biochemistry; 1997 May; 36(21):6495-501. PubMed ID: 9174367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of active ribozymes from an RNA pool of random sequences using an anchored substrate RNA.
    Ishizaka M; Ohshima Y; Tani T
    Biochem Biophys Res Commun; 1995 Sep; 214(2):403-9. PubMed ID: 7545903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro evolution of the hammerhead ribozyme to a purine-specific ribozyme using mutagenic PCR with two nucleotide analogues.
    Kore AR; Vaish NK; Morris JA; Eckstein F
    J Mol Biol; 2000 Sep; 301(5):1113-21. PubMed ID: 10966809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examination of the catalytic fitness of the hammerhead ribozyme by in vitro selection.
    Tang J; Breaker RR
    RNA; 1997 Aug; 3(8):914-25. PubMed ID: 9257650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hammerhead ribozymes designed to cleave all human rod opsin mRNAs which cause autosomal dominant retinitis pigmentosa.
    Sullivan JM; Pietras KM; Shin BJ; Misasi JN
    Mol Vis; 2002 Apr; 8():102-13. PubMed ID: 11961505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selecting allosteric ribozymes.
    Piganeau N
    Methods Mol Biol; 2012; 848():317-28. PubMed ID: 22315077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ribozyme-targeted destruction of RNA associated with autosomal-dominant retinitis pigmentosa.
    Drenser KA; Timmers AM; Hauswirth WW; Lewin AS
    Invest Ophthalmol Vis Sci; 1998 Apr; 39(5):681-9. PubMed ID: 9538873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attempts to obtain more efficient GAC-cleaving hammerhead ribozymes by in vitro selection.
    Kore AR; Carola C; Eckstein F
    Bioorg Med Chem; 2000 Jul; 8(7):1767-71. PubMed ID: 10976525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro optimization of truncated stem-loop II variants of the hammerhead ribozyme for cleavage in low concentrations of magnesium under non-turnover conditions.
    Zillmann M; Limauro SE; Goodchild J
    RNA; 1997 Jul; 3(7):734-47. PubMed ID: 9214657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered RNase P ribozymes inhibit gene expression and growth of cytomegalovirus by increasing rate of cleavage and substrate binding.
    Trang P; Hsu A; Zhou T; Lee J; Kilani AF; Nepomuceno E; Liu F
    J Mol Biol; 2002 Jan; 315(4):573-86. PubMed ID: 11812131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of hammerhead ribozyme variants with low Mg2+ requirement: importance of stem-loop II.
    Persson T; Hartmann RK; Eckstein F
    Chembiochem; 2002 Nov; 3(11):1066-71. PubMed ID: 12404631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro selection of allosteric ribozymes: theory and experimental validation.
    Piganeau N; Thuillier V; Famulok M
    J Mol Biol; 2001 Oct; 312(5):1177-90. PubMed ID: 11580234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of fast purine nucleotide synthase ribozymes.
    Lau MW; Cadieux KE; Unrau PJ
    J Am Chem Soc; 2004 Dec; 126(48):15686-93. PubMed ID: 15571390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro selection of hammerhead ribozymes containing a bulged nucleotide in stem II.
    Thomson JB; Sigurdsson ST; Zeuch A; Eckstein F
    Nucleic Acids Res; 1996 Nov; 24(22):4401-6. PubMed ID: 8948630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro evolution suggests multiple origins for the hammerhead ribozyme.
    Salehi-Ashtiani K; Szostak JW
    Nature; 2001 Nov; 414(6859):82-4. PubMed ID: 11689947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro selection of a purine nucleotide-specific hammerheadlike ribozyme.
    Vaish NK; Heaton PA; Fedorova O; Eckstein F
    Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2158-62. PubMed ID: 9482855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of hammerhead ribozyme kinetic constants at high molar ratio ribozyme-substrate.
    Grassi G; Grassi M; Kuhn A; Kandolf R
    J Math Biol; 2002 Sep; 45(3):261-77. PubMed ID: 12373347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clone, expression and cleavage activity of anti-caspase-7 hammerhead ribozyme in vitro].
    Zhang W; Xie Q; Zhou XQ; Jiang S; Jin YX
    Zhonghua Gan Zang Bing Za Zhi; 2004 Nov; 12(11):684-7. PubMed ID: 15623380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro evolution and characterization of a ligase ribozyme adapted to acidic conditions: effect of further rounds of evolution.
    Miyamoto Y; Teramoto N; Imanishi Y; Ito Y
    Biotechnol Bioeng; 2005 Apr; 90(1):36-45. PubMed ID: 15723313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Satellite cereal yellow dwarf virus-RPV (satRPV) RNA requires a douXble hammerhead for self-cleavage and an alternative structure for replication.
    Song SI; Silver SL; Aulik MA; Rasochova L; Mohan BR; Miller WA
    J Mol Biol; 1999 Nov; 293(4):781-93. PubMed ID: 10543967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.